Gip News

29 Aug 20261:33 am

medicine29 Aug 2026 · 1:33 am1:33 am

FDA Approves Mounjaro to Lower Risk of Heart Events in Diabetics

The U.S. Food and Drug Administration (FDA) has approved Mounjaro to reduce the risk of heart events, including heart attacks, in individuals with diabetes. Dev

18 Aug 20263:26 pm

Business18 Aug 2026 · 3:26 pm3:26 pm

Create visual

Inox Clean Energy Completes ₹6,000 Crore Acquisition of Vena Energy India

Inox Clean Energy has successfully completed the acquisition of BlackRock-owned GIP's Vena Energy India for Rs 6,000 crore within two months. This strategic mov

30 Jul 20267:30 pm

Biotechnology30 Jul 2026 · 7:30 pm7:30 pm

Create visual

RenaissThera Advances Oral Drug Development for Obesity and Type 2 Diabetes

RenaissThera, a Bengaluru-based company founded in 2023, is developing oral small-molecule drugs for obesity and type 2 diabetes, focusing on targets like GLP-1

Gip News

#Gip

FDA Approves Mounjaro to Lower Risk of Heart Events in Diabetics

Inox Clean Energy Completes ₹6,000 Crore Acquisition of Vena Energy India

RenaissThera Advances Oral Drug Development for Obesity and Type 2 Diabetes

Discover Faster

Stay Organized

Create Effortlessly

Newsroom FAQs

Drive Greater Impact